Inhibiting Oestrogen Signalling in Pulmonary Arterial Hypertension: Sex, Drugs and Research

Overview

Journal Eur Respir J

Specialty Pulmonary Medicine

Date 2017 Aug 5

PMID 28775051

Citations 7

Authors

Tim Lahm

Steven M Kawut

Affiliations

Soon will be listed here.

Citing Articles

Sex Differences in Pulmonary Hypertension.

Rodriguez-Arias J, Garcia-Alvarez A Front Aging. 2022; 2:727558.

PMID: 35822006 PMC: 9261364. DOI: 10.3389/fragi.2021.727558.

Insulin Resistance Is Associated with Right Ventricular Dysfunction.

Min J, Putt M, Yang W, Al-Naamani N, Bertoni A, Lima J Ann Am Thorac Soc. 2021; 19(4):562-571.

PMID: 34499590 PMC: 8996272. DOI: 10.1513/AnnalsATS.202107-766OC.

Newer insights into the pathobiological and pharmacological basis of the sex disparity in patients with pulmonary arterial hypertension.

Hye T, Dwivedi P, Li W, Lahm T, Nozik-Grayck E, Stenmark K Am J Physiol Lung Cell Mol Physiol. 2021; 320(6):L1025-L1037.

PMID: 33719549 PMC: 8285629. DOI: 10.1152/ajplung.00559.2020.

Estradiol Metabolism: Crossroads in Pulmonary Arterial Hypertension.

Tofovic S, Jackson E Int J Mol Sci. 2019; 21(1).

PMID: 31877978 PMC: 6982327. DOI: 10.3390/ijms21010116.

Exogenous Estrogen Preserves Distal Pulmonary Arterial Mechanics and Prevents Pulmonary Hypertension in Rats.

Philip J, Tabima D, Wolf G, Frump A, Cheng T, Schreier D Am J Respir Crit Care Med. 2019; 201(3):371-374.

PMID: 31661294 PMC: 6999110. DOI: 10.1164/rccm.201906-1217LE.

References

White K, Johansen A, Nilsen M, Ciuclan L, Wallace E, Paton L . Activity of the estrogen-metabolizing enzyme cytochrome P450 1B1 influences the development of pulmonary arterial hypertension. Circulation. 2012; 126(9):1087-98. DOI: 10.1161/CIRCULATIONAHA.111.062927. View

Lahm T, Patel K, Crisostomo P, Markel T, Wang M, Herring C . Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycle. Am J Physiol Endocrinol Metab. 2007; 293(3):E865-71. DOI: 10.1152/ajpendo.00201.2007. View

Olsson K, Delcroix M, Ghofrani H, Tiede H, Huscher D, Speich R . Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation. 2013; 129(1):57-65. DOI: 10.1161/CIRCULATIONAHA.113.004526. View

Pare G, Krust A, Karas R, Dupont S, Aronovitz M, Chambon P . Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res. 2002; 90(10):1087-92. DOI: 10.1161/01.res.0000021114.92282.fa. View

Kawut S, Al-Naamani N, Agerstrand C, Rosenzweig E, Rowan C, Barst R . Determinants of right ventricular ejection fraction in pulmonary arterial hypertension. Chest. 2008; 135(3):752-759. PMC: 2834785. DOI: 10.1378/chest.08-1758. View

Liu A, Tian L, Golob M, Eickhoff J, Boston M, Chesler N . 17β-Estradiol Attenuates Conduit Pulmonary Artery Mechanical Property Changes With Pulmonary Arterial Hypertension. Hypertension. 2015; 66(5):1082-8. PMC: 4600044. DOI: 10.1161/HYPERTENSIONAHA.115.05843. View

Liu A, Schreier D, Tian L, Eickhoff J, Wang Z, Hacker T . Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol. 2014; 307(3):H273-83. PMC: 4121651. DOI: 10.1152/ajpheart.00758.2013. View

Murphy E . Estrogen signaling and cardiovascular disease. Circ Res. 2011; 109(6):687-96. PMC: 3398381. DOI: 10.1161/CIRCRESAHA.110.236687. View

Mair K, Wright A, Duggan N, Rowlands D, Hussey M, Roberts S . Sex-dependent influence of endogenous estrogen in pulmonary hypertension. Am J Respir Crit Care Med. 2014; 190(4):456-67. PMC: 4214128. DOI: 10.1164/rccm.201403-0483OC. View

10.

Ventetuolo C, Mitra N, Wan F, Manichaikul A, Barr R, Johnson C . Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function. Eur Respir J. 2015; 47(2):553-63. PMC: 4831135. DOI: 10.1183/13993003.01083-2015. View

11.

Foderaro A, Ventetuolo C . Pulmonary Arterial Hypertension and the Sex Hormone Paradox. Curr Hypertens Rep. 2016; 18(11):84. DOI: 10.1007/s11906-016-0689-7. View

12.

Wallace T, Levy J, Matthews D . Use and abuse of HOMA modeling. Diabetes Care. 2004; 27(6):1487-95. DOI: 10.2337/diacare.27.6.1487. View

13.

Jacobs W, van de Veerdonk M, Trip P, de Man F, Heymans M, Marcus J . The right ventricle explains sex differences in survival in idiopathic pulmonary arterial hypertension. Chest. 2013; 145(6):1230-1236. PMC: 4042511. DOI: 10.1378/chest.13-1291. View

14.

Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V . Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010; 122(2):156-63. DOI: 10.1161/CIRCULATIONAHA.109.911818. View

15.

Lahm T, Tuder R, Petrache I . Progress in solving the sex hormone paradox in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2014; 307(1):L7-26. DOI: 10.1152/ajplung.00337.2013. View

16.

Ellis M, Llombart-Cussac A, Feltl D, Dewar J, Jasiowka M, Hewson N . Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST Study. J Clin Oncol. 2015; 33(32):3781-7. PMC: 4737861. DOI: 10.1200/JCO.2015.61.5831. View

17.

Kawut S, Archer-Chicko C, DeMichele A, Fritz J, Klinger J, Ky B . Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial. Am J Respir Crit Care Med. 2016; 195(3):360-368. PMC: 5328182. DOI: 10.1164/rccm.201605-1024OC. View

18.

Ventetuolo C, Ouyang P, Bluemke D, Tandri H, Barr R, Bagiella E . Sex hormones are associated with right ventricular structure and function: The MESA-right ventricle study. Am J Respir Crit Care Med. 2010; 183(5):659-67. PMC: 3081282. DOI: 10.1164/rccm.201007-1027OC. View

19.

Chen X, Talati M, Fessel J, Hemnes A, Gladson S, French J . Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism. Circulation. 2015; 133(1):82-97. PMC: 4698046. DOI: 10.1161/CIRCULATIONAHA.115.016133. View

20.

Newman J, Rich S, Abman S, Alexander J, Barnard J, Beck G . Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report. Am J Respir Crit Care Med. 2017; 195(12):1661-1670. PMC: 5476915. DOI: 10.1164/rccm.201701-0150WS. View